Preparation and in vitro evaluation of surface-modified poly (lactide-co-glycolide) microparticles as biodegradable drug carriers for pulmonary peptide and protein delivery. (1st April 2014)

• Record Type: Journal Article
• Authors: Devrim, Burcu; Bozkır, Asuman
• Is Part Of: Journal of microencapsulation. Volume 31:Number 4(2014:Jun.)
• Page Start: 355
• Page End: 362
• Publication Date: 2014-04-01
• Subjects: Microparticle -- mucoadhesion -- mucoadhesive polymers -- poly(lactide-co-glycolide) -- pulmonary peptide/protein delivery -- surface modification; Microencapsulation -- Periodicals; Controlled release technology -- Periodicals; 615.19
• DOI: 10.3109/02652048.2013.858791
• Languages: English
• ISSNs: 0265-2048

Abstract

Abstract: The present study reports the preparation and physicochemical characterization of surface-modified poly(lactide- co -glycolide) (PLGA) microparticles containing interleukin-2 (rhIL-2) for pulmonary delivery. The surface of the microparticles was modified with mucoadhesive polymers such as chitosan and Carbopol 971P. The feasibility of this surface modification was confirmed by measuring the zeta potential. Chitosan-modified PLGA microparticles showed a positive zeta potential, while Carbopol-modified PLGA microparticles were negatively charged. The mucin binding efficiency values have shown that the positively charged chitosan coated microparticles showed a higher adhesive percent to the mucin than the negatively charged un-coated or Carbopol 971P coated microparticles. Furthermore, surface modification of microparticles with chitosan and Carbopol 971P has yielded a slight decrease in the amount of protein initially released. These findings suggest the suitability of surface-modified PLGA microparticles as an efficient carrier system for delivery peptides and proteins to the respiratory tract.